Unknown

Dataset Information

0

Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators.

ABSTRACT: The present study describes the discovery and characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as G protein-gated inwardly-rectifying potassium (GIRK) channel activators. From our previous lead optimization efforts, we have identified a new ether-based scaffold and paired this with a novel sulfone-based head group to identify a potent and selective GIRK1/2 activator. In addition, we evaluated the compounds in tier 1 DMPK assays and have identified compounds that display nanomolar potency as GIRK1/2 activators with improved metabolic stability over the prototypical urea-based compounds.

SUBMITTER: Sharma S 

PROVIDER: S-EPMC8372201 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Discovery, synthesis and biological characterization of a series of <i>N</i>-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1<i>H</i>-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators.

Sharma Swagat S   Lesiak Lauren L   Aretz Christopher D CD   Du Yu Y   Kumar Sushil S   Gautam Nagsen N   Alnouti Yazen Y   Dhuria Nikilesh V NV   Chhonker Yashpal S YS   Weaver C David CD   Hopkins Corey R CR  

RSC medicinal chemistry 20210621 8

The present study describes the discovery and characterization of a series of <i>N</i>-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1<i>H</i>-pyrazol-5-yl)acetamide ethers as G protein-gated inwardly-rectifying potassium (GIRK) channel activators. From our previous lead optimization efforts, we have identified a new ether-based scaffold and paired this with a novel sulfone-based head group to identify a potent and selective GIRK1/2 activator. In addition, we evaluated the compounds in tier 1  ...[more]

Similar Datasets

Unknown Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.
| S-EPMC6398930 | biostudies-literature
Unknown Structural elements in the Girk1 subunit that potentiate G protein-gated potassium channel activity.
| S-EPMC3535602 | biostudies-literature
Unknown 2-Chloro-N-[3-cyano-1-(3,4-dichloro-phen-yl)-1H-pyrazol-5-yl]acetamide.
| S-EPMC3344093 | biostudies-literature
Unknown 2-Chloro-N-[1-(4-chloro-phen-yl)-3-cyano-1H-pyrazol-5-yl]acetamide.
| S-EPMC3515326 | biostudies-literature
Unknown 1,1'-Bis(1-acetyl-5-methyl-1H-pyrazol-3-yl)ferrocene.
| S-EPMC3246958 | biostudies-literature
Unknown 2-Chloro-N-{3-cyano-1-[2,6-dichloro-4-(trifluoro-meth-yl)phen-yl]-1H-pyrazol-5-yl}acetamide.
| S-EPMC3254452 | biostudies-literature
Unknown Potassium channel activators differentially modulate the effect of sodium channel blockade on cardiac conduction.
| S-EPMC3980511 | biostudies-literature
Unknown [1,1'-Bis(diphenyl-phosphino)ferrocene]carbon-yl[dihydro-bis(pyrazol-1-yl)borato]hydridoruthenium(II) acetone solvate.
| S-EPMC2960072 | biostudies-literature
Unknown N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[4-(methyl-sulfan-yl)phen-yl]acetamide.
| S-EPMC3435699 | biostudies-literature
Unknown 2-(2,4-Dichloro-phen-yl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)acetamide.
| S-EPMC3588232 | biostudies-literature